PT3122330T - Composições farmacêuticas compreendendo levocetirizina - Google Patents
Composições farmacêuticas compreendendo levocetirizinaInfo
- Publication number
- PT3122330T PT3122330T PT15712898T PT15712898T PT3122330T PT 3122330 T PT3122330 T PT 3122330T PT 15712898 T PT15712898 T PT 15712898T PT 15712898 T PT15712898 T PT 15712898T PT 3122330 T PT3122330 T PT 3122330T
- Authority
- PT
- Portugal
- Prior art keywords
- levocetirizine
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- ZKLPARSLTMPFCP-OAQYLSRUSA-N 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1[C@@H](C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-OAQYLSRUSA-N 0.000 title 1
- 229960001508 levocetirizine Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14161997 | 2014-03-27 | ||
| EP14162001 | 2014-03-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3122330T true PT3122330T (pt) | 2018-11-13 |
Family
ID=52774233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT15712898T PT3122330T (pt) | 2014-03-27 | 2015-03-26 | Composições farmacêuticas compreendendo levocetirizina |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20170105988A1 (pt) |
| EP (1) | EP3122330B1 (pt) |
| JP (2) | JP6506301B2 (pt) |
| KR (1) | KR102445606B1 (pt) |
| CN (2) | CN106102715A (pt) |
| BR (1) | BR112016022126B1 (pt) |
| CA (1) | CA2940920C (pt) |
| DK (1) | DK3122330T3 (pt) |
| EA (1) | EA036278B1 (pt) |
| ES (1) | ES2691920T3 (pt) |
| HU (1) | HUE039791T2 (pt) |
| MX (1) | MX371443B (pt) |
| PL (1) | PL3122330T3 (pt) |
| PT (1) | PT3122330T (pt) |
| WO (1) | WO2015144830A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102110304B1 (ko) * | 2017-06-30 | 2020-05-14 | 한미약품 주식회사 | 레보세티리진 및 몬테루카스트를 포함하는 안정성 및 복약순응도가 향상된 복합 츄어블정 및 그 제조방법 |
| JP6986244B2 (ja) * | 2017-09-27 | 2021-12-22 | 高田製薬株式会社 | レボセチリジン固形製剤 |
| WO2022069956A1 (en) * | 2020-09-29 | 2022-04-07 | Millicent Pharma Limited | Orodispersible formulations |
| EP4247331A1 (en) | 2020-11-18 | 2023-09-27 | BioPharma Synergies, S. L. | Orodispersible powder composition comprising an antihistamine compound |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1011251A3 (fr) * | 1997-07-03 | 1999-06-01 | Ucb Sa | Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine. |
| CN101632642B (zh) * | 2002-01-15 | 2011-06-08 | Ucb法奇姆股份有限公司 | 口感和稳定性改善的配方 |
| US20060083786A1 (en) * | 2004-07-29 | 2006-04-20 | Glenmark Pharmaceuticals Limited | Taste masking pharmaceutical composition containing levocetirizine |
| US8962022B2 (en) * | 2007-03-27 | 2015-02-24 | Aptalis Pharmatech, Inc. | Pharmaceutical compositions comprising an active substance from the substituted benzhydrylpiperazine family |
| JP5461179B2 (ja) * | 2007-06-06 | 2014-04-02 | 旭化成ケミカルズ株式会社 | セルロース系微小核粒子及びその製造方法 |
| JP5291324B2 (ja) * | 2007-11-01 | 2013-09-18 | 沢井製薬株式会社 | 口腔内崩壊錠 |
| WO2011110939A2 (en) * | 2010-03-11 | 2011-09-15 | Rubicon Research Private Limited | Pharmaceutical compositions of substituted benzhydrylpiperazines |
| JP2013159587A (ja) * | 2012-02-07 | 2013-08-19 | Riken Vitamin Co Ltd | レイヤリング用核粒子の製造方法 |
| JP6176840B2 (ja) * | 2012-06-29 | 2017-08-09 | 高田製薬株式会社 | フェキソフェナジン顆粒製剤及びその製造方法 |
| CN102860986A (zh) * | 2012-09-28 | 2013-01-09 | 天津市聚星康华医药科技有限公司 | 一种稳定的掩味的左西替利嗪药物组合物及其制备方法 |
-
2015
- 2015-03-26 EP EP15712898.4A patent/EP3122330B1/en active Active
- 2015-03-26 KR KR1020167023021A patent/KR102445606B1/ko active IP Right Grant
- 2015-03-26 ES ES15712898.4T patent/ES2691920T3/es active Active
- 2015-03-26 CA CA2940920A patent/CA2940920C/en active Active
- 2015-03-26 MX MX2016011401A patent/MX371443B/es active IP Right Grant
- 2015-03-26 EA EA201691924A patent/EA036278B1/ru not_active IP Right Cessation
- 2015-03-26 WO PCT/EP2015/056593 patent/WO2015144830A1/en active Application Filing
- 2015-03-26 JP JP2016557610A patent/JP6506301B2/ja active Active
- 2015-03-26 CN CN201580015287.8A patent/CN106102715A/zh active Pending
- 2015-03-26 US US15/129,365 patent/US20170105988A1/en not_active Abandoned
- 2015-03-26 HU HUE15712898A patent/HUE039791T2/hu unknown
- 2015-03-26 BR BR112016022126-5A patent/BR112016022126B1/pt active IP Right Grant
- 2015-03-26 PT PT15712898T patent/PT3122330T/pt unknown
- 2015-03-26 DK DK15712898.4T patent/DK3122330T3/en active
- 2015-03-26 PL PL15712898T patent/PL3122330T3/pl unknown
- 2015-03-26 CN CN202010619821.9A patent/CN111632023A/zh active Pending
-
2018
- 2018-07-19 JP JP2018135483A patent/JP6820116B2/ja active Active
-
2020
- 2020-01-23 US US16/750,702 patent/US20200297718A1/en not_active Abandoned
-
2021
- 2021-03-03 US US17/191,365 patent/US20210251984A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EA036278B1 (ru) | 2020-10-21 |
| WO2015144830A1 (en) | 2015-10-01 |
| JP6506301B2 (ja) | 2019-04-24 |
| MX2016011401A (es) | 2017-04-06 |
| PL3122330T3 (pl) | 2019-01-31 |
| US20170105988A1 (en) | 2017-04-20 |
| KR20160137521A (ko) | 2016-11-30 |
| US20200297718A1 (en) | 2020-09-24 |
| HUE039791T2 (hu) | 2019-02-28 |
| JP6820116B2 (ja) | 2021-01-27 |
| BR112016022126A2 (pt) | 2021-08-03 |
| BR112016022126B1 (pt) | 2023-05-02 |
| JP2018184436A (ja) | 2018-11-22 |
| EP3122330A1 (en) | 2017-02-01 |
| CN111632023A (zh) | 2020-09-08 |
| CN106102715A (zh) | 2016-11-09 |
| MX371443B (es) | 2020-01-30 |
| ES2691920T3 (es) | 2018-11-29 |
| US20210251984A1 (en) | 2021-08-19 |
| CA2940920A1 (en) | 2015-10-01 |
| JP2017508761A (ja) | 2017-03-30 |
| EP3122330B1 (en) | 2018-07-25 |
| KR102445606B1 (ko) | 2022-09-20 |
| DK3122330T3 (en) | 2018-10-22 |
| EA201691924A1 (ru) | 2017-02-28 |
| CA2940920C (en) | 2023-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1225655A1 (zh) | 包含azd9291的藥用組合物 | |
| IL246978A0 (en) | New paracetamol formulations | |
| GB201618482D0 (en) | Pharmaceutical compositions | |
| GB201419257D0 (en) | Pharmaceutical compositions | |
| GB201409471D0 (en) | Pharmaceutical composition | |
| IL249553A0 (en) | Pharmaceutical preparations | |
| GB201409485D0 (en) | Pharmaceutical composition | |
| GB201409488D0 (en) | Pharmaceutical composition | |
| ZA201702086B (en) | Long acting pharmaceutical compositions | |
| PT3122330T (pt) | Composições farmacêuticas compreendendo levocetirizina | |
| HK1245073A1 (zh) | 藥物組合物 | |
| ZA201502073B (en) | Pharmaceutical composition | |
| IL250817A0 (en) | pharmaceutical preparations | |
| ZA201508726B (en) | Pharmaceutical composition | |
| PT3200772T (pt) | Composições farmacêuticas compreendendo alpelisib | |
| PT3089740T (pt) | Composição farmacêutica | |
| ZA201500995B (en) | Low dose pharmaceutical composition | |
| GB201417589D0 (en) | Pharmaceutical Formulations | |
| SG10201504332VA (en) | Pharmaceutical Composition | |
| PT3319596T (pt) | Composições farmacêuticas | |
| SG2014014872A (en) | Pharmaceutical compositions | |
| GB201408432D0 (en) | Pharmaceutical compositions | |
| GB201506598D0 (en) | Pharmaceutical compositions |